2.4 ML risankizumab-rzaa 150 MG/ML Cartridge [Skyrizi]
RxNorm concept 2604628, branded drug (sbd). Prescribable name: Skyrizi 360 MG in 2.4 ML Cartridge.
- RxCUI
- 2604628
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2604628 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
2.4 ML Skyrizi 150 MG/ML Cartridge; Skyrizi 360 MG per 2.4 ML Cartridge
Related concepts
- risankizumab-rzaa 150 MG/ML (SCDC, consists of)
- risankizumab-rzaa 150 MG/ML [Skyrizi] (SBDC, consists of)
- Cartridge (DF, has dose form)
- Skyrizi (BN, has ingredient)
- 2.4 ML risankizumab-rzaa 150 MG/ML Cartridge (SCD, tradename of)
Linked data
NDCs
- 00074106901
- 00074106902
- 00074107001
- 00074107002
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2604628 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2604628 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2604628. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.